C4d in IgA nephropathy: a marker sans boundaries

C4d in IgA nephropathy: a marker sans boundaries

Bibliographic Details
Main Author:	Muhammed Mubarak
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2016-04-01
Series:	Journal of Nephropharmacology
Subjects:	IgA nephropathy Oxford classification system C4d Rapidly progressive glomerulonephritis
Online Access:	http://jnephropharmacology.com/PDF/NPJ-5-102.pdf

Similar Items

Evaluation of Clinical and Pathological Characteristics of Patients with IgA Nephropathy Based on Oxford Classification System: Should Crescents be Included?
by: Ersan Sibel, et al.
Published: (2017-06-01)

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
by: Le Weibo, et al.
Published: (2012-11-01)

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
by: Rafaela C.G. Fabiano, et al.
Published: (2017-07-01)

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
by: Rafaela C.G. Fabiano, et al.

Updated Oxford classification for IgA nephropathy; current status and future prospects
by: Hamid Nasri, et al.
Published: (2019-01-01)

Oxford classification of IgA nephropathy and C4d deposition; correlation and its implication
by: Ashutosh Rath, et al.
Published: (2016-04-01)

Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report
by: Tadasu Kojima, et al.
Published: (2019-01-01)

Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival
by: Yeter Hasan Haci, et al.
Published: (2020-12-01)

The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study
by: Heyan Wu, et al.
Published: (2020-07-01)

Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience
by: N Imai, et al.
Published: (2016-01-01)

IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences
by: Živile Riispere, et al.
Published: (2016-01-01)

A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease
by: Choi Ji-Young, et al.
Published: (2012-08-01)

Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli
by: Flavia Teodora Ioana Paunas, et al.
Published: (2019-11-01)

IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis
by: Brenda Navarro de Souza, et al.
Published: (2018-05-01)

Oxford Classification of IgA Nephropathy Is Applicable to Predict Long-Term Outcomes of Henoch-Schönlein Purpura Nephritis
by: Hamid Nasri
Published: (2014-12-01)

Primary IgA nephropathy: current challenges and future prospects
by: Penfold RS, et al.
Published: (2018-04-01)

Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)
by: Judith Isabel Schimpf, et al.
Published: (2018-11-01)

Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
by: Mayuko Kawabe, et al.
Published: (2020-09-01)

The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
by: Tae Ryom Oh, et al.
Published: (2021-01-01)

Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy
by: Gyl Eanes Barros Silva, et al.
Published: (2012-07-01)

Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
by: Daniela Castelo Azevedo, et al.
Published: (2011-02-01)

Infection-related immunoglobulin A nephropathy or IgA-dominant postinfectious glomerulonephritis; what is in a name?
by: Ghazal Ghasempoor Dabaghi, et al.
Published: (2021-07-01)

Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers
by: Amir Taherkhani, et al.
Published: (2019-12-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018-03-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China
by: Lu Huan, et al.
Published: (2016-05-01)

Clinical Significance of Crescent Formation in IgA Nephropathy – a Multicenter Validation Study
by: Sehoon Park, et al.
Published: (2019-02-01)

Hepatitis C as a potential cause of IgA nephropathy
by: A K Dey, et al.
Published: (2013-01-01)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
by: Haresh Selvaskandan, et al.
Published: (2020-10-01)

Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study
by: Tong-dan Bi, et al.
Published: (2019-07-01)

The origin and activities of IgA1-containing immune complexes in IgA nephropathy
by: Barbora eKnoppova, et al.
Published: (2016-04-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2017-11-01)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
by: Soumita Bagchi, et al.
Published: (2021-06-01)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients
by: Yen-Ling Chiu, et al.
Published: (2021-06-01)